AmplideX® PCR/CE CFTR Kit

Cystic fibrosis (CF) is a life-limiting, autosomal recessive disease caused by the presence of pathogenic alterations in the CFTR gene. While CFTR variants are prevalent in Caucasian and Ashkenazi Jewish populations, they also occur in other groups. Furthermore, recent studies show that many existing CFTR mutation panels do not include mutations frequently found in other ethnicities, which can lead to reduced detection rates in diverse populations.

Informed by recent large-scale, population studies, the AmplideX® PCR/CE CFTR Kit has been designed to detect approximately 93% of the pathogenic CFTR variants observed in the U.S. population. As a result, it provides broader coverage than any other commercially available, targeted testing kit. The assay also includes push-button data analysis software to provide a simple, streamlined, and scalable testing solution that delivers meaningful results in under five hours. The test shares a common workflow with other assays in the AmplideX product portfolio and is optimized for use on widely established laboratory equipment.